Canakinumab in a case of adult onset still's disease: efficacy only on systemic manifestations

Joint Bone Spine. 2014 Jul;81(4):376-7. doi: 10.1016/j.jbspin.2013.12.011. Epub 2014 Jan 23.

Authors

Alberto Lo Gullo¹, Andrea Caruso², Nicolò Pipitone², Pierluigi Macchioni², Giulia Pazzola², Carlo Salvarani²

Affiliations

¹ University of Messina, Policlinico G. Martino, Department of Clinical and Experimental Medicine, Messina, Italy. Electronic address: [email protected].
² Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.

PMID: 24462130
DOI: 10.1016/j.jbspin.2013.12.011

No abstract available

Keywords: Adult-onset Still disease; Canakinumab; IL-1β blockade; Ultrasonography.

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Antirheumatic Agents / therapeutic use*
Female
Humans
Interleukin-1beta / antagonists & inhibitors*
Still's Disease, Adult-Onset / drug therapy*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Interleukin-1beta
canakinumab